MCP effectively binds to recombinant Gal-3 and inhibits Gal-3-mediated functions, such as homotypic tumor cell aggregation, binding of tumor to endothelial cells, anchorage-independent growth, angiogenesis and tumor-infiltrating lymphocyte impairment [125]. The gene discussed is LGALS3; the disease is neoplasm.